-
cmext.ahrq.gov/confluence/download/export/pdfexport-20230731-310723-2229-525/LHS+Case+Study_b27aaa0e6dd64a16a6dd5d5a24e100ab-310723-2229-526.pdf?contentType=application/pdf
August 31, 2021 - COVID-19 Multiplatform RCT EvidenceReport ( ): a critically https://fevir.net/18816
appraised summary (risk … COVID-19 RAPID trial RCT EvidenceReport ( ): a critically https://fevir.net/18824
appraised summary (risk
-
cmext.ahrq.gov/confluence/pages/viewpage.action?pageId=114991763
September 09, 2021 - Wood Johnson Foundation to convene broad stakeholder groups in identifying and harmonizing social risk
-
cmext.ahrq.gov/confluence/pages/viewpage.action?pageId=114991687
September 15, 2021 - Wood Johnson Foundation to convene broad stakeholder groups in identifying and harmonizing social risk
-
cmext.ahrq.gov/confluence/pages/viewpage.action?navigatingVersions=true&pageId=114991687
September 15, 2021 - Wood Johnson Foundation to convene broad stakeholder groups in identifying and harmonizing social risk
-
cmext.ahrq.gov/confluence/pages/viewpage.action?navigatingVersions=true&pageId=114991763
September 09, 2021 - Wood Johnson Foundation to convene broad stakeholder groups in identifying and harmonizing social risk
-
cmext.ahrq.gov/confluence/pages/diffpagesbyversion.action?originalVersion=10&pageId=114990890&revisedVersion=17
September 10, 2021 - COVID-19 Multiplatform RCT EvidenceReport ( https://fevir.net/18816 ): a critically appraised summary (risk … COVID-19 RAPID trial RCT EvidenceReport ( https://fevir . net/18824 ): a critically appraised summary (risk
-
cmext.ahrq.gov/confluence/pages/diffpagesbyversion.action?pageId=114991797&selectedPageVersions=1&selectedPageVersions=2
September 19, 2021 - Lack of incentives for full interoperability creates significant risk of anticompetitive practices to … _Toc63957767 _Toc63957767 Anchor _Toc65858307 _Toc65858307 Future State Vision The environmental risks … available assets, gauge suitability for purpose, understand supporting evidence, and estimate costs/risks … HL7 DaVinci) IP protections; leaking of proprietary/confidential information; reverse engineering of risk … Relying too heavily on vendor momentum in this area presents risk of skewing operational policies to
-
cmext.ahrq.gov/confluence/pages/viewpage.action?pageId=114991105
October 01, 2021 - evidence and guidance computable—based on the use case of a Collaborative-linked NACHC ambulatory COVID risk … continual enhancement of the ecosystem to utilize it for other focus areas (e.g., anticoagulation, risk … These targets include treatment with anticoagulants and steroids, risk assessment and triage in ambulatory
-
cmext.ahrq.gov/confluence/pages/viewpage.action?pageId=114991751
October 01, 2021 - evidence and guidance computable—based on the use case of a Collaborative-linked NACHC ambulatory COVID risk … continual enhancement of the ecosystem to utilize it for other focus areas (e.g., anticoagulation, risk … These targets include treatment with anticoagulants and steroids, risk assessment and triage in ambulatory
-
cmext.ahrq.gov/confluence/pages/viewpage.action?pageId=114991748
October 01, 2021 - evidence and guidance computable—based on the use case of a Collaborative-linked NACHC ambulatory COVID risk … continual enhancement of the ecosystem to utilize it for other focus areas (e.g., anticoagulation, risk … These targets include treatment with anticoagulants and steroids, risk assessment and triage in ambulatory
-
cmext.ahrq.gov/confluence/pages/viewpage.action?pageId=114991761
October 01, 2021 - evidence and guidance computable—based on the use case of a Collaborative-linked NACHC ambulatory COVID risk … continual enhancement of the ecosystem to utilize it for other focus areas (e.g., anticoagulation, risk … These targets include treatment with anticoagulants and steroids, risk assessment and triage in ambulatory
-
cmext.ahrq.gov/confluence/pages/diffpages.action?originalId=114991751&pageId=114991748
September 20, 2021 - evidence and guidance computable—based on the use case of a Collaborative-linked NACHC ambulatory COVID risk … continual enhancement of the ecosystem to utilize it for other focus areas (e.g., anticoagulation, risk … These targets include treatment with anticoagulants and steroids, risk assessment and triage in ambulatory
-
cmext.ahrq.gov/confluence/pages/diffpages.action?originalId=114991748&pageId=114991105
September 20, 2021 - evidence and guidance computable—based on the use case of a Collaborative-linked NACHC ambulatory COVID risk … continual enhancement of the ecosystem to utilize it for other focus areas (e.g., anticoagulation, risk … These targets include treatment with anticoagulants and steroids, risk assessment and triage in ambulatory
-
cmext.ahrq.gov/confluence/pages/viewpage.action?navigatingVersions=true&pageId=114991761
October 01, 2021 - evidence and guidance computable—based on the use case of a Collaborative-linked NACHC ambulatory COVID risk … continual enhancement of the ecosystem to utilize it for other focus areas (e.g., anticoagulation, risk … These targets include treatment with anticoagulants and steroids, risk assessment and triage in ambulatory
-
cmext.ahrq.gov/confluence/pages/viewpage.action?navigatingVersions=true&pageId=114991751
October 01, 2021 - evidence and guidance computable—based on the use case of a Collaborative-linked NACHC ambulatory COVID risk … continual enhancement of the ecosystem to utilize it for other focus areas (e.g., anticoagulation, risk … These targets include treatment with anticoagulants and steroids, risk assessment and triage in ambulatory
-
cmext.ahrq.gov/confluence/pages/diffpagesbyversion.action?originalVersion=3&pageId=114991105&revisedVersion=5
September 20, 2021 - evidence and guidance computable—based on the use case of a Collaborative-linked NACHC ambulatory COVID risk … continual enhancement of the ecosystem to utilize it for other focus areas (e.g., anticoagulation, risk … These targets include treatment with anticoagulants and steroids, risk assessment and triage in ambulatory
-
cmext.ahrq.gov/confluence/pages/diffpagesbyversion.action?originalVersion=1&pageId=114991105&revisedVersion=5
September 20, 2021 - evidence and guidance computable—based on the use case of a Collaborative-linked NACHC ambulatory COVID risk … continual enhancement of the ecosystem to utilize it for other focus areas (e.g., anticoagulation, risk … These targets include treatment with anticoagulants and steroids, risk assessment and triage in ambulatory
-
cmext.ahrq.gov/confluence/pages/viewpage.action?navigatingVersions=true&pageId=114991748
October 01, 2021 - evidence and guidance computable—based on the use case of a Collaborative-linked NACHC ambulatory COVID risk … continual enhancement of the ecosystem to utilize it for other focus areas (e.g., anticoagulation, risk … These targets include treatment with anticoagulants and steroids, risk assessment and triage in ambulatory
-
cmext.ahrq.gov/confluence/pages/diffpagesbyversion.action?pageId=114991748&selectedPageVersions=3&selectedPageVersions=4
September 20, 2021 - evidence and guidance computable—based on the use case of a Collaborative-linked NACHC ambulatory COVID risk … continual enhancement of the ecosystem to utilize it for other focus areas (e.g., anticoagulation, risk … These targets include treatment with anticoagulants and steroids, risk assessment and triage in ambulatory
-
cmext.ahrq.gov/confluence/pages/diffpagesbyversion.action?originalVersion=4&pageId=114991105&revisedVersion=5
September 20, 2021 - evidence and guidance computable—based on the use case of a Collaborative-linked NACHC ambulatory COVID risk … continual enhancement of the ecosystem to utilize it for other focus areas (e.g., anticoagulation, risk … These targets include treatment with anticoagulants and steroids, risk assessment and triage in ambulatory